News

The epigenetic clock could inform us about how swiftly we age, and how prone we are to diseases of old age.

Researchers from Baylor College of Medicine and the University of Pittsburgh have gathered more than 80 studies, reviewed the data, and identified commonalities that are helping to paint a broader picture of how COVID-19 affects the brain.

A new study by researchers at UC Santa Cruz shows how a genetic mutation throws off the timing of the biological clock, causing a common sleep syndrome called delayed sleep phase disorder.

Scientists have discovered a way to halt the growth of glioblastoma, a deadly brain cancer. The team has devised a new tactic in the war against cancer that involves reprogramming the immune system to fight the tumor, rather than fueling it.

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

Research led by investigators provides new hope for recovery from degenerative neurological diseases as well as from damage caused by traumatic brain and spine injuries and stroke.

A new USC-led study suggests a change to the developmental story of the pituitary gland. Researchers now present evidence that, in some vertebrates, the endoderm also forms part of the pituitary's front lobe -- an idea that has been the subject of scientific controversy dating back more than 100 years.

DNA variation in a gene called ROBO1 is associated with early anatomical differences in a brain region that plays a key role in quantity representation, potentially explaining how genetic variability might shape mathematical performance in children, according to a new study.

A new study describes a novel algorithm to compare the 3D genomes of cancer patients with that of a healthy reference.

Researchers at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, together with colleagues at the University Hospital Carl Gustav Carus Dresden, previously identified a number of molecular players.